Andra AP fonden reduced its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 34.3% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 22,200 shares of the company’s stock after selling 11,600 shares during the period. Andra […]
Advisor OS LLC boosted its position in iShares Russell 1000 Value ETF (NYSEARCA:IWD – Free Report) by 12.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,593 shares of the exchange traded fund’s stock after buying an additional 179 shares during the quarter. […]
Operose Advisors LLC trimmed its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 4.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 423 shares of the company’s stock after selling 22 shares during the quarter. Operose Advisors […]
Sheaff Brock Investment Advisors LLC trimmed its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 4.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 41,961 shares of the company’s stock after selling 2,124 shares during the quarter. Eli Lilly […]
Column Capital Advisors LLC lifted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.1% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 787,836 shares of the company’s stock after buying an additional 622 shares during the quarter. Eli […]